Russell Investments Group, Ltd. - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 91 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 42.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$4,000
-98.1%
1,828
-97.8%
0.00%
Q4 2020$210,000
-62.2%
84,351
-68.6%
0.00%
-100.0%
Q3 2020$555,000
+795.2%
268,672
+1228.2%
0.00%
Q2 2020$62,000
+37.8%
20,2280.0%0.00%
Q1 2020$45,000
+45.2%
20,228
+230.6%
0.00%
Q2 2018$31,000
-42.6%
6,119
-23.1%
0.00%
Q1 2018$54,000
-8.5%
7,9610.0%0.00%
Q4 2017$59,0007,9610.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Prosight Management, LP 1,360,000$6,895,0005.06%
Omega Fund Management, LLC 778,230$3,946,0002.91%
BVF INC/IL 5,346,838$27,108,0002.65%
Virtus ETF Advisers LLC 152,550$773,0000.68%
SPHERA FUNDS MANAGEMENT LTD. 842,632$4,272,0000.59%
Tekla Capital Management LLC 2,087,380$10,583,0000.40%
Schonfeld Strategic Advisors LLC 828,600$4,201,0000.23%
Orbimed Advisors 3,140,000$15,920,0000.19%
Lombard Odier Asset Management (USA) Corp 563,878$2,859,0000.19%
Rhenman & Partners Asset Management AB 300,000$1,521,0000.16%
View complete list of PIERIS PHARMACEUTICALS INC shareholders